No takes yet. Share an insight, caveat, or question.
Analysis reveals limiting skin dose benefits radiotherapy planning in breast cancer patients, indicating lower irradiated dose but no significant skin reaction decrease.
Fu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: